Department of Urology, All India Institute of Medical Sciences (AIIMS) Jammu, has commenced advanced endourological services, ...

December 16, 2025 Is the era within which a TURP was performed associated with differences in reoperation rates, specific surgical side effects, or the requirement for BPH medicat ...

As medical technology continues to evolve, patients today have access to treatment options that are less invasive, offer quicker recovery, and better support long-term quality of life. These ...

While age has always been the strongest risk factor for benign prostatic hyperplasia (BPH), ethnicity and lifestyle factors also play a big role in its onset. W ...

EkitiThe Chief Medical Director of Afe Babalola University Multi-System Hospital (AMSH), Ado-Ekiti, Dr Akinola Akinmade, has said that the hospital is beginning to reverse medical tourism to overseas ...

The Afe Babalola University Multi-System Hospital (AMSH), Ado-Ekiti, has recorded another major breakthrough in Nigeria’s healthcare sector with the successful completion of 40 kidney transplant ...

The procedure marks a significant advancement in urological surgery and men’s health American Hospital Dubai has achieved a groundbreaking medical milestone with the successful completion of the ...

Before having cataract surgery, any person who has ever taken an alpha blocker should tell their eye surgeon. Tamsulosin is ...

ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...

The prostatic urethral stent for relief of lower urinary tract symptoms from benign prostatic hyperplasia (BPH) was tested in the ProVide trial.

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it ...